SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

NATURES SUNSHINE PRODUCTS INC
Date: June 12, 2025 · CIK: 0000275053 · Accession: 0000000000-25-006237

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287882

Date
June 12, 2025
Author
Division of
Form
UPLOAD
Company
NATURES SUNSHINE PRODUCTS INC

Letter

Re: Nature s Sunshine Products, Inc. Registration Statement on Form S-3 Filed June 9, 2025 File No. 333-287882 Dear Nathan Brower:

June 12, 2025

Nathan Brower EVP, General Counsel and Corporate Secretary Nature s Sunshine Products, Inc. 2901 West Bluegrass Blvd., Suite 100 Lehi, Utah 84043

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tim Buchmiller at 202-551-3635 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Dan Lyman, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 June 12, 2025

Nathan Brower
EVP, General Counsel and Corporate Secretary
Nature s Sunshine Products, Inc.
2901 West Bluegrass Blvd., Suite 100
Lehi, Utah 84043

 Re: Nature s Sunshine Products, Inc.
 Registration Statement on Form S-3
 Filed June 9, 2025
 File No. 333-287882
Dear Nathan Brower:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Tim Buchmiller at 202-551-3635 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Dan Lyman, Esq.
</TEXT>
</DOCUMENT>